Cargando…

In vitro efficiency of Amikacin Inhale, a novel drug-device delivery system

Detalles Bibliográficos
Autores principales:	Kadrichu, N, Boc, S, Corkery, K, Challoner, P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643084/ http://dx.doi.org/10.1186/cc12019

Ejemplares similares

Performance of amikacin inhale: impact of supplemental oxygen and device orientation
por: Kadrichu, N, et al.
Publicado: (2015)

NKTR-061 (inhaled amikacin) delivers high lung doses in mechanically ventilated patients with pneumonia and in healthy subjects
por: Eldon, M, et al.
Publicado: (2008)

High epithelial lining fluid concentrations of NKTR-061 (inhaled amikacin) twice daily achieved in pneumonic portions of lung
por: Chastre, J, et al.
Publicado: (2008)

Inhaled ceftazidime and amikacin versus inhaled colistin in the treatment of gram negative ventilator associated pneumonia
por: Nassar, YS, et al.
Publicado: (2015)

Sputum concentration of amikacin varies with nebulizer efficiency measured in vitro in patients on mechanical ventilators
por: Dequin, P, et al.
Publicado: (2004)

Decrease in intravenous antibiotic use with adjunctive aerosolized amikacin treatment in intubated mechanically ventilated patients with Gram-negative pneumonia
por: Niederman, M, et al.
Publicado: (2007)

Intrathecal administration of colistin, vancomycin and amikacin for central nervous system infections in ICU neurosurgical patients
por: Alexandropoulos, P, et al.
Publicado: (2015)

Analysis of parameters in critically ill patients influencing amikacin peak levels
por: Hollevoet, IM, et al.
Publicado: (2013)

Laryngitis after inhalation of liposomal amikacin
por: Morita, Atsuho, et al.
Publicado: (2022)

Design and assessment of an adherence monitoring device for inhalers
por: Costello, Richard, et al.
Publicado: (2013)

Novel drug delivery system using acoustic control of intratumoral drug distribution
por: Kawabata, Ken-ichi, et al.
Publicado: (2015)

Adsorption of amikacin during continuous venovenous haemofiltration in a swine model of acute renal failure
por: Gomersall, CD, et al.
Publicado: (2015)

Liposomal Amikacin Inhalation Suspension-induced Pneumonitis
por: Kidogawa, Moe, et al.
Publicado: (2022)

Impact of an inducement to give high doses of amikacin and gentamicin on serum concentrations in critically ill patients with severe sepsis
por: Roger, C, et al.
Publicado: (2015)

Anti-staphylococcal activity resulting from epithelial lining fluid (ELF) concentrations of amikacin inhale administered via the pulmonary drug delivery system
por: Ghazi, Islam M., et al.
Publicado: (2017)

Amikacin Liposome Inhalation Suspension (ALIS) Penetrates Non-tuberculous Mycobacterial Biofilms and Enhances Amikacin Uptake Into Macrophages
por: Zhang, Jimin, et al.
Publicado: (2018)

Dry powder inhaled compound delivery for early pre-clinical in vivo efficacy studies
por: Ives, Robert, et al.
Publicado: (2013)

Evaluating the efficacy of inhaled amikacin as an adjunct to intravenous combination therapy (ceftazidime and amikacin) in pediatric cystic fibrosis pulmonary exacerbation
por: Rakhshan, Amin, et al.
Publicado: (2023)

Inhalation drug delivery devices: technology update
por: Ibrahim, Mariam, et al.
Publicado: (2015)

Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia
por: Luyt, Charles-Edouard, et al.
Publicado: (2009)

Intravaginal immunization using a novel antigen delivery device elicits robust vaccine antigen-specific systemic and mucosal humoral immune responses
por: McKay, PF, et al.
Publicado: (2012)

PK/PD of single-dose amikacin in emergency department patients with severe sepsis/shock: should we apply the ICU-based higher loading dose?
por: Winter, S De, et al.
Publicado: (2015)

Characterisation of a novel vaccine delivery system for livestock
por: McLean, Rebecca K, et al.
Publicado: (2015)

805. Amikacin Liposome Inhalation Suspension (ALIS) Add-on Therapy for Refractory Mycobacterium avium Complex (MAC) Lung Disease: Effect of In Vitro Amikacin Susceptibility on Sputum Culture Conversion
por: Brown-Elliott, Barbara A, et al.
Publicado: (2018)

Device for measuring bronchodilator delivery and response in resource-limited settings
por: Carspecken, CW, et al.
Publicado: (2013)

A device for ventilation-analogue mechanostimulation in vitro
por: Gamerdinger, K, et al.
Publicado: (2012)

Positive Effect of Liposomal Amikacin for Inhalation on Mycobacterium abcessus in Cystic Fibrosis Patients
por: Caimmi, Davide, et al.
Publicado: (2018)

Novel small scale TFF cell retention device for perfusion cell culture systems
por: Martin, Chris S, et al.
Publicado: (2015)

Can high efficiency aerosol delivery continue after extubation?
por: Fink, J, et al.
Publicado: (2005)

Inhalation injury in critical burn patients
por: Cachafeiro, L, et al.
Publicado: (2013)

Adrenal suppression in an asthmatic presenting after change from high dose inhaled fluticasone propionate to inhaled budesonide
por: Abdurahman, Zainab B, et al.
Publicado: (2010)

An improved Bussignac device for the delivery of noninvasive continuous positive airway pressure: the SUPER-Bussignac
por: Bellani, G, et al.
Publicado: (2008)

P11-12. A novel vaginal ring device for the sustained delivery of recombinant C-clade HIV-1 CN54gp140
por: Morrow, RJ, et al.
Publicado: (2009)

Long-term safety of inhaled corticosteroids in children
por: Pedersen, S
Publicado: (2010)

Efficacy of inhaled tobramycin in severe nosocomial pneumonia
por: Kuzovlev, A, et al.
Publicado: (2012)

Inhaled tobramycin for the treatment of nosocomial pneumonia in sepsis
por: Kuzovlev, A, et al.
Publicado: (2014)

Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease
por: Shirley, Matt
Publicado: (2019)

The clinical and genetic factors for predicting the response to inhaled corticosteroids
por: Nagase, Hiroyuki, et al.
Publicado: (2013)

Anaphylaxis by inhalation of allergenic proteins from Anisakis simplex
por: Garcia Navarro, Dalhila Janett, et al.
Publicado: (2013)

Inhalation injury and clinical course in major burned patients
por: Henrich, S, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_01to4cbpdj414e0o32rh51c4br